Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2024-09-09 Purchase | 2024-09-11 5:46 pm | RELMADA THERAPEUTICS INC. | RLMD | Shenouda Maged Chief Financial Officer | 53,432 | $2.8017 | $149,701 | 88,335 (Direct) | View |
2024-01-29 Purchase | 2024-01-31 6:28 pm | RELMADA THERAPEUTICS INC. | RLMD | Shenouda Maged Chief Financial Officer | 32,675 | $3.8475 | $125,717 | 34,903 (Direct) | View |
2021-03-08 Sale | 2021-03-10 6:18 pm | RELMADA THERAPEUTICS INC. | RLMD | Shenouda Maged CFO | 10,000 | $35.45 | $354,507 | 72,578 (Direct) | View |
2021-02-24 Sale | 2021-02-26 4:48 pm | RELMADA THERAPEUTICS INC. | RLMD | Shenouda Maged CFO | 3,000 | $34.18 | $102,529 | 82,478 (Direct) | View |
2021-02-11 Sale | 2021-02-16 5:08 pm | RELMADA THERAPEUTICS INC. | RLMD | Shenouda Maged CFO | 1,428 | $35.39 | $50,542 | 85,478 (Direct) | View |
2021-02-08 Sale | 2021-02-10 7:25 pm | RELMADA THERAPEUTICS INC. | RLMD | Shenouda Maged CFO | 11,372 | $35.17 | $399,910 | 86,906 (Direct) | View |
2021-02-02 Sale | 2021-02-04 5:38 pm | RELMADA THERAPEUTICS INC. | RLMD | Shenouda Maged CFO | 3,200 | $35.04 | $112,134 | 98,278 (Direct) | View |
2021-01-27 Sale | 2021-01-29 5:24 pm | RELMADA THERAPEUTICS INC. | RLMD | Shenouda Maged CFO | 3,000 | $31.93 | $95,778 | 101,478 (Direct) | View |
2021-01-22 Sale | 2021-01-26 7:28 pm | RELMADA THERAPEUTICS INC. | RLMD | Shenouda Maged CFO | 4,000 | $35.4 | $141,612 | 104,478 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2024-05-24 Option Award | 2024-05-29 9:24 pm | 2024-03-15 2033-12-15 | RELMADA THERAPEUTICS INC. | RLMD | Shenouda Maged Chief Financial Officer | 54,624 | $0 | 218,804 (Direct) | View |
2024-05-24 Other | 2024-05-29 9:24 pm | 2024-03-15 2033-12-15 | RELMADA THERAPEUTICS INC. | RLMD | Shenouda Maged Chief Financial Officer | 54,624 | $0 | 218,804 (Direct) | View |
2023-12-15 Option Award | 2023-12-19 5:28 pm | 2024-03-15 2033-12-15 | RELMADA THERAPEUTICS INC. | RLMD | Shenouda Maged Chief Financial Officer | 82,090 | $0 | 82,090 (Direct) | View |
2023-05-25 Option Award | 2023-05-30 5:09 pm | 2023-03-16 2032-12-16 | RELMADA THERAPEUTICS INC. | RLMD | Shenouda Maged Chief Financial Officer | 317,643 | $0 | 512,560 (Direct) | View |
2022-12-16 Other | 2022-12-20 7:31 pm | N/A 2031-12-17 | RELMADA THERAPEUTICS INC. | RLMD | Shenouda Maged CFO | 200,000 | $0 | 0 (Direct) | View |
2022-12-16 Option Award | 2022-12-20 5:34 pm | 2023-03-16 2032-12-16 | RELMADA THERAPEUTICS INC. | RLMD | Shenouda Maged Chief Financial Officer | 194,917 | $0 | 194,917 (Direct) | View |
2022-05-25 Option Award | 2022-05-26 6:42 pm | 2022-03-17 2031-12-17 | RELMADA THERAPEUTICS INC. | RLMD | Shenouda Maged Chief Financial Officer | 495,211 | $0 | 722,729 (Direct) | View |
2021-12-17 Option Award | 2021-12-21 9:30 pm | 2022-03-17 2031-12-17 | RELMADA THERAPEUTICS INC. | RLMD | Shenouda Maged Chief Financial Officer | 227,518 | $0 | 227,518 (Direct) | View |
2021-03-08 Exercise | 2021-03-10 6:18 pm | 2017-10-20 2027-10-20 | RELMADA THERAPEUTICS INC. | RLMD | Shenouda Maged CFO | 10,000 | $0 | 72,578 (Direct) | View |
2021-03-08 Exercise | 2021-03-10 6:18 pm | N/A N/A | RELMADA THERAPEUTICS INC. | RLMD | Shenouda Maged CFO | 10,000 | $3.24 | 72,578 (Direct) | View |
2021-02-24 Exercise | 2021-02-26 4:48 pm | 2017-10-20 2027-10-20 | RELMADA THERAPEUTICS INC. | RLMD | Shenouda Maged CFO | 3,000 | $0 | 82,478 (Direct) | View |
2021-02-24 Exercise | 2021-02-26 4:48 pm | N/A N/A | RELMADA THERAPEUTICS INC. | RLMD | Shenouda Maged CFO | 3,000 | $3.24 | 82,478 (Direct) | View |
2021-02-11 Exercise | 2021-02-16 5:08 pm | 2017-10-20 2027-10-20 | RELMADA THERAPEUTICS INC. | RLMD | Shenouda Maged CFO | 1,428 | $0 | 85,478 (Direct) | View |
2021-02-11 Exercise | 2021-02-16 5:08 pm | N/A N/A | RELMADA THERAPEUTICS INC. | RLMD | Shenouda Maged CFO | 1,428 | $3.24 | 85,478 (Direct) | View |
2021-02-08 Exercise | 2021-02-10 7:25 pm | 2017-10-20 2027-10-20 | RELMADA THERAPEUTICS INC. | RLMD | Shenouda Maged CFO | 11,372 | $0 | 86,906 (Direct) | View |
2021-02-08 Exercise | 2021-02-10 7:25 pm | N/A N/A | RELMADA THERAPEUTICS INC. | RLMD | Shenouda Maged CFO | 11,372 | $3.24 | 86,906 (Direct) | View |
2021-02-02 Exercise | 2021-02-04 5:38 pm | 2017-10-20 2027-10-20 | RELMADA THERAPEUTICS INC. | RLMD | Shenouda Maged CFO | 3,200 | $0 | 98,278 (Direct) | View |
2021-02-02 Exercise | 2021-02-04 5:38 pm | N/A N/A | RELMADA THERAPEUTICS INC. | RLMD | Shenouda Maged CFO | 3,200 | $3.24 | 98,278 (Direct) | View |
2021-01-27 Exercise | 2021-01-29 5:24 pm | 2017-10-20 2027-10-20 | RELMADA THERAPEUTICS INC. | RLMD | Shenouda Maged CFO | 3,000 | $0 | 101,478 (Direct) | View |
2021-01-27 Exercise | 2021-01-29 5:24 pm | N/A N/A | RELMADA THERAPEUTICS INC. | RLMD | Shenouda Maged CFO | 3,000 | $3.24 | 101,478 (Direct) | View |
2021-01-22 Exercise(A) | 2021-01-27 07:46 am | N/A N/A | RELMADA THERAPEUTICS INC. | RLMD | Shenouda Maged CFO | 4,000 | $3.24 | 6,228 (Direct) | View |
2021-01-22 Exercise | 2021-01-26 7:28 pm | 2017-10-20 2027-10-20 | RELMADA THERAPEUTICS INC. | RLMD | Shenouda Maged CFO | 4,000 | $0 | 104,478 (Direct) | View |
2021-01-22 Exercise | 2021-01-26 7:28 pm | N/A N/A | RELMADA THERAPEUTICS INC. | RLMD | Shenouda Maged CFO | 4,000 | $324 | 104,478 (Direct) | View |
2021-01-07 Option Award | 2021-01-11 4:07 pm | 2021-04-07 2031-01-07 | RELMADA THERAPEUTICS INC. | RLMD | Shenouda Maged CFO | 255,000 | $0 | 255,000 (Direct) | View |
2019-12-19 Option Award | 2019-12-23 4:51 pm | N/A 2029-12-19 | RELMADA THERAPEUTICS INC. | RLMD | Shenouda Maged Director | 120,000 | $43.47 | 120,000 (Direct) | View |